CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on improving lung transplantation outcomes by developing a technique called ex vivo lung perfusion (EVLP). This method assesses lung quality before transplantation, potentially increasing the number of usable donor lungs and enhancing patient survival rates.
Lung transplantation is the only therapeutic option for selected patients suffering from end-stage lung diseases. 80% of all donated lungs are not used for transplantation.
The main reason is uncertainty of the function and quality of the lung.
Ex vivo lung perfusion (EVLP) is a technique used to assess quality of lungs prior to transplantation.
In collaboration with leading clinical scientists, XVIVO has developed solutions and systems for EVLP. EVLP has recently become internationally clinical…
XVIVO PERFUSION AKTIEBOLAG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
